AMERICAN SHARED HOSPITAL SERVICES Increase (Decrease) in Deferred Revenue
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Increase (Decrease) in Deferred Revenue of -$84.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2017-11-13
- 2017-09-30: Increase (Decrease) in Deferred Revenue 9 month -$84.00K.
- 2016-09-30: Increase (Decrease) in Deferred Revenue 9 month -$186.00K.
| Period end | Increase (Decrease) in Deferred Revenue 9 month |
|---|---|
| 2017-09-30 | -$84.00K 10-Q · filed 2017-11-13 |
| 2016-09-30 | -$186.00K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |